info@example.com

+1 66589 14556

Rezūm vs UroLift: Which Is Better?

Rezūm vs UroLift: Which Is Better?

📖 6 min read Written/reviewed by Dr. Alhad Naragude, MBBS, MS, DrNB Urology Last updated: September 6, 2026

Rezūm and UroLift are both minimally invasive treatments for bothersome urinary symptoms from benign prostate enlargement, but neither is universally “better.” UroLift opens the channel immediately with permanent implants and often gives the quickest recovery with excellent ejaculation preservation. Rezūm injects steam into obstructing tissue; early swelling means a catheter is more commonly needed and improvement takes several weeks, but it leaves no permanent implant and can treat selected median lobes. Both generally preserve sexual function better than TURP or HoLEP. Prostate size, median-lobe anatomy, severity of obstruction and willingness to accept retreatment usually decide between them.

Quick comparison

Feature Rezūm UroLift
Mechanism Steam causes targeted tissue necrosis and gradual shrinkage. Permanent implants retract the obstructing lobes.
Onset Gradual; improvement develops over weeks. Often relatively rapid once irritation settles.
Catheter Commonly needed temporarily. Often avoidable, but not always.
Median lobe Selected median lobes can be treated. Guideline selection is more restrictive; EAU recommends mainly no middle lobe.
Ejaculation Usually preserved. Usually preserved.
Tissue / implant No permanent implant; tissue is ablated. Permanent implants remain in the prostate.
Retreatment Possible over time. Higher reintervention than TURP in long-term data.
Best fit Moderate gland, gradual shrinkage acceptable. Suitable lateral-lobe anatomy and priority for fastest recovery.

What Rezūm means

Rezūm is water vapour thermal therapy. A cystoscopic device delivers short steam injections into selected prostate zones. The treated tissue dies and is slowly cleared by the body. The procedure can address lateral lobes and selected median lobes, but swelling before shrinkage makes catheterisation and delayed benefit part of the expected experience.

What UroLift means

UroLift is a prostatic urethral lift. Small implants are placed through a cystoscope to retract the enlarged side lobes and hold the urinary channel open. No prostate tissue is removed or thermally destroyed. The trade-off for a quick recovery is less powerful de-obstruction than TURP and a greater chance of needing another procedure later.

When Rezūm may be preferred

  • A median lobe contributes to obstruction and is suitable for steam treatment.
  • The patient wants to avoid a permanent implant.
  • A few days of catheterisation and gradual improvement are acceptable.
  • The prostate is within the evidence-supported size range for water vapour therapy.

When UroLift may be preferred

  • Preserving ejaculation and returning to routine activity quickly are the highest priorities.
  • The prostate has favourable lateral-lobe anatomy without an obstructive middle lobe under the chosen guideline/device criteria.
  • The patient wants to minimise the chance of a postoperative catheter.
  • The patient accepts permanent implants and a higher retreatment probability than TURP.

Benefits and limitations that matter most

Neither treatment usually matches the objective flow improvement of a strong tissue-removing operation in a severely obstructed prostate. Rezūm has the advantage of no permanent implant and broader median-lobe applicability; UroLift has the advantage of a very rapid mechanical opening and often less catheter dependence. Both should be framed as trade-offs rather than “small TURPs.”

One important difference: guideline maturity

The two procedures do not sit in exactly the same place in current guidelines. The 2026 EAU guideline strongly recommends UroLift for selected men with prostates under 70 mL and no middle lobe who want to preserve ejaculation, while advising that retreatment is higher than after TURP. Rezūm has useful randomised and five-year data but remains listed by the EAU among ablative techniques under investigation because direct comparisons with reference surgery are still limited.

Recovery differences

After UroLift, burning, urgency, pelvic discomfort and blood in the urine usually settle over days to a few weeks, and many men return to light work quickly. After Rezūm, early swelling may worsen flow temporarily; a catheter is commonly used and the improvement develops over several weeks. Heavy exercise and cycling are avoided until bleeding and discomfort settle with either procedure.

The anatomy usually breaks the tie

Consider a man with a 50-60 mL prostate, mainly lateral-lobe obstruction, a low residual urine and no history of retention. If his priority is the quickest recovery and avoiding a catheter, UroLift may fit well. If the same man has a significant median lobe or strongly wants to avoid permanent implants, Rezūm may be more logical. If he instead has repeated retention, a bladder stone or a residual of several hundred millilitres, the more important question is whether either minimally invasive option is strong enough.

  • Lateral-lobe anatomy with no obstructing middle lobe favours the standard UroLift selection pathway.
  • A treatable median lobe or a wish to avoid permanent implants can shift the balance toward Rezūm.
  • Tolerance for a temporary catheter matters more with Rezūm; tolerance for permanent implants matters more with UroLift.
  • High residual urine, recurrent retention, stones or kidney effects should trigger comparison with TURP, HoLEP or another stronger de-obstructive operation rather than forcing a choice between these two.

Emergency warning signs

  • Complete inability to pass urine, especially with a painful or distended lower abdomen.
  • Fever or rigors together with difficulty passing urine, retention or a catheter that is not draining.
  • Heavy bleeding or blood clots that block urine flow.
  • A catheter stops draining and the bladder feels increasingly full or painful.
  • Vomiting, marked weakness, confusion or feeling seriously unwell while urinary obstruction is suspected.

What to bring for consultation

  • Ultrasound with prostate volume and post-void residual.
  • Uroflowmetry if available.
  • Urine routine/culture and serum creatinine.
  • PSA report when clinically relevant.
  • Medication list, especially alpha blockers, 5-alpha-reductase inhibitors and blood thinners.
  • Records of catheterisation, retention or previous prostate procedures.

FAQs

Which preserves ejaculation better?

Both have favourable ejaculation-preservation profiles. UroLift has particularly strong evidence for maintaining ejaculatory function, while Rezūm also has a low incidence of new ejaculatory dysfunction.

Which improves urine flow faster?

UroLift usually opens the channel sooner. Rezūm relies on tissue shrinkage over weeks.

Which is better for a median lobe?

Rezūm is generally the more established choice of the two for selected obstructing median lobes. UroLift median-lobe treatment exists, but guideline recommendations remain more restrictive.

Which is more durable?

Both can require retreatment. Direct head-to-head long-term evidence is limited, so durability should not be reduced to a single number.

What if I already have a catheter for retention?

Either may be inappropriate if obstruction is severe or bladder function is poor. Retention should trigger a more complete evaluation before choosing a minimally invasive therapy.

Related reading

References

Note: This information is for educational purposes only and is not a substitute for medical advice. Please consult your doctor for any symptoms.